Company Monitoring Page for Actavis

latest headlines for company on cafepharma

Allergan Confirms White Knight Approach By Actavis, But Coyly
WSJ Online
Mon, 11/3/14 - 03:46 pm
Tags:
Allergan, M&A, Valeant Pharmaceuticals, Actavis
Allergan says has been approached by another party about a deal
Yahoo/Reuters
Mon, 11/3/14 - 11:59 am
Tags:
Allergan, Valeant Pharmaceuticals, M&A, Actavis
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
Mon, 11/3/14 - 08:57 am
Tags:
M&A, Actavis, Forest Labs, GSK, Novartis, Bayer, Merck, Mallinckrodt, Questcor Pharmaceuticals, Eli Lilly, Idenix, Nestle, Galderma, Sun Pharma, Ranbaxy, Aptalis, Abbott Labs, CFR
Actavis Q3 Earnings Preview: Solid Results Expected On The Back Of Recent Acquisitions
Bidness Etc.
Mon, 11/3/14 - 08:43 am
Tags:
Actavis, earnings
Actavis CEO Saunders Has $70 Billion in Deals to Choose From
Bloomberg
Fri, 10/24/14 - 08:02 am
Tags:
Actavis, M&A, Brent Saunders, Allergan, Pfizer, Omega Pharma, Salix
Actavis Said to Compete With Sanofi for Omega Pharma Deal
Bloomberg
Mon, 10/20/14 - 06:37 pm
Tags:
Actavis, Sanofi, Omega Pharma, M&A
Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?
Motley Fool
Thu, 10/9/14 - 05:10 pm
Tags:
Actavis, Allergan, Valeant Pharmaceuticals, M&A
Actavis deal for Allergan would be huge bet on branded drugs
Yahoo/Reuters
Wed, 10/8/14 - 08:31 pm
Tags:
Actavis, Allergan, M&A
[video]Actavis plans new Allergan approach: Report
CNBC
Tue, 10/7/14 - 04:53 pm
Tags:
Actavis, Allergan, M&A, Valeant Pharmaceuticals
Salix: The Field of Potential Buyers is Vast, Analyst Says
WSJ Online
Tue, 10/7/14 - 04:52 pm
Tags:
Salix, M&A, Actavis, Allergan, AstraZeneca, Takeda
Actavis buying Durata Therapeutics for $616.4
Yahoo/AP
Mon, 10/6/14 - 09:18 am
Tags:
Actavis, Durata Therapeutics, M&A
Some ETFs Saying a Salix Takeover Could be Afoot
Yahoo/ETFTrends
Fri, 10/3/14 - 04:24 pm
Tags:
Salix, M&A, Actavis
Salix Said in Talks to Sell to Actavis as Allergan Fades
Bloomberg
Thu, 10/2/14 - 07:56 pm
Tags:
Salix, Actavis, Allergan, M&A
Five Reasons Celgene Could Gain 20%
Barron's
Mon, 09/29/14 - 01:52 pm
Tags:
Celgene, Actavis
What Actavis Did Not Want You to See in That Antitrust Lawsuit
WSJ Pharmalot
Fri, 09/26/14 - 09:06 am
Tags:
Actavis, antitrust, Alzheimer's disease, Namenda XR, Forest Labs
Actavis agrees to keep making original version of its Alzheimer's drug for a while
Fierce Pharma
Thu, 09/25/14 - 10:33 pm
Tags:
Actavis, Alzheimer's disease, Namenda XR
Pfizer explored takeover of rival Actavis
Marketwatch
Wed, 09/24/14 - 07:54 am
Tags:
Pfizer, Actavis, tax inversions, M&A
Pfizer Said to Approach Actavis to Gauge Interest in Deal
Bloomberg
Tue, 09/23/14 - 04:56 pm
Tags:
Pfizer, Actavis, M&A
Will Allergan Acquire Salix, Or Be Acquired Itself?
Bidness Etc.
Tue, 09/23/14 - 07:45 am
Tags:
Allergan, Salix, Valeant Pharmaceuticals, Actavis, M&A
Botox maker Allergan rejected Actavis takeover bid
Morningstar
Mon, 09/22/14 - 10:17 pm
Tags:
Allergan, Actavis, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.